APA (7th ed.) Citation

YT, X., YM, Z., HX, Y., LF, Y., F, C., X, L., . . . QL, P. (2022). Evaluation and validation of the prognostic value of anti-MDA5 IgG subclasses in dermatomyositis-associated interstitial lung disease. Rheumatology (Oxford, England), 62(1), 397. https://doi.org/10.1093/rheumatology/keac229

Chicago Style (17th ed.) Citation

YT, Xu, Zhang YM, Yang HX, Ye LF, Chen F, Lu X, Wang GC, and Peng QL. "Evaluation and Validation of the Prognostic Value of Anti-MDA5 IgG Subclasses in Dermatomyositis-associated Interstitial Lung Disease." Rheumatology (Oxford, England) 62, no. 1 (2022): 397. https://doi.org/10.1093/rheumatology/keac229.

MLA (9th ed.) Citation

YT, Xu, et al. "Evaluation and Validation of the Prognostic Value of Anti-MDA5 IgG Subclasses in Dermatomyositis-associated Interstitial Lung Disease." Rheumatology (Oxford, England), vol. 62, no. 1, 2022, p. 397, https://doi.org/10.1093/rheumatology/keac229.